{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3C protease", "Colorimetric assay.", "Common cold", "Inhibition", "Molecular docking", "Phytochemicals"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38698747", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "24"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "24"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0115680266308561240427065854"], "ArticleDate": [], "Journal": {"ISSN": "1873-4294", "JournalIssue": {"Volume": "24", "Issue": "15", "PubDate": {"Year": "2024"}}, "Title": "Current topics in medicinal chemistry", "ISOAbbreviation": "Curr Top Med Chem"}, "ArticleTitle": "Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold.", "Pagination": {"StartPage": "1343", "EndPage": "1358", "MedlinePgn": "1343-1358"}, "Abstract": {"AbstractText": ["Human rhinovirus 3C protease (HRV-3C<sup>pro</sup>) plays a crucial role in viral proliferation, establishing it as a prime target for antiviral therapy. However, research on identifying HRV-3C<sup>pro</sup> inhibitors is still limited.", "This study had two primary objectives: first, to validate the efficacy of an end-point colorimetric assay, previously developed by our team, for identifying potential inhibitors of HRV-3C<sup>pro</sup>; and second, to discover phytochemicals in medicinal plants that inhibit the enzyme's activity.", "Rupintrivir, a well-known inhibitor of HRV-3C<sup>pro</sup>, was used to validate the colorimetric assay. Following this, we conducted a two-step in silico screening of 2532 phytochemicals, which led to the identification of eight active compounds: apigenin, carnosol, chlorogenic acid, kaempferol, luteolin, quercetin, rosmarinic acid, and rutin. We subsequently evaluated these candidates in vitro. To further investigate the inhibitory potential of the most promising candidates, namely, carnosol and rosmarinic acid, molecular docking studies were performed to analyze their binding interactions with HRV-3C<sup>pro</sup>.", "The colorimetric assay we previously developed is effective in identifying compounds that selectively inhibit HRV-3C<sup>pro</sup>. Carnosol and rosmarinic acid emerged as potent inhibitors, inhibiting HRV-3C<sup>pro</sup> activity in vitro by over 55%. Our analysis indicated that carnosol and rosmarinic acid exert their inhibitory effects through a competitive mechanism. Molecular docking confirmed their competitive binding to the enzyme's active site.", "Carnosol and rosmarinic acid warrant additional investigation for their potential in the development of common cold treatment. By highlighting these compounds as effective HRV-3C<sup>pro</sup> inhibitors, our study presents a promising approach for discovering phytochemical inhibitors against proteases from similar pathogens."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, 2417, Nicosia, Cyprus."}], "LastName": "Tsilimingkra", "ForeName": "Nefeli Theodora", "Initials": "NT"}, {"Identifier": ["0000-0002-4045-8839"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417, Nicosia, Cyprus."}], "LastName": "Papaneophytou", "ForeName": "Christos", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Top Med Chem", "NlmUniqueID": "101119673", "ISSNLinking": "1568-0266"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "3C Viral Proteases"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "chemistry", "isolation & purification"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "3C Viral Proteases"}, {"QualifierName": ["enzymology", "drug effects"], "DescriptorName": "Rhinovirus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Common Cold"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Viral Proteins"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Protease Inhibitors"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Eccles R.; Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005,5(11),718-725", "ArticleIdList": ["10.1016/S1473-3099(05)70270-X", "16253889"]}, {"Citation": "Moriyama M.; Hugentobler W.J.; Iwasaki A.; Seasonality of respiratory viral infections. Annu Rev Virol 2020,7(1),83-101", "ArticleIdList": ["10.1146/annurev-virology-012420-022445", "32196426"]}, {"Citation": "Wat D.; The common cold: A review of the literature. Eur J Intern Med 2004,15(2),79-88", "ArticleIdList": ["10.1016/j.ejim.2004.01.006", "15172021"]}, {"Citation": "Greenberg S.B.; Allen M.; Wilson J.; Atmar R.L.; Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000,162(1),167-173", "ArticleIdList": ["10.1164/ajrccm.162.1.9911019", "10903237"]}, {"Citation": "Hendley J.O.; Epidemiology, pathogenesis, and treatment of the common cold. Semin Pediatr Infect Dis 1998,9(1),50-55", "ArticleIdList": ["10.1016/S1045-1870(98)80051-4", "32288450"]}, {"Citation": "Tuthill T.J.; Groppelli E.; Hogle J.M.; Rowlands D.J.; Picornaviruses. Curr Top Microbiol Immunol 2010,343,43-89", "ArticleIdList": ["10.1007/82_2010_37", "20397067"]}, {"Citation": "Passioti M.; Maggina P.; Megremis S.; Papadopoulos N.G.; The common cold: Potential for future prevention or cure. Curr Allergy Asthma Rep 2014,14(2),413", "ArticleIdList": ["10.1007/s11882-013-0413-5", "24415465"]}, {"Citation": "Palmenberg A.C.; Spiro D.; Kuzmickas R.; Wang S.; Djikeng A.; Rathe J.A.; Liggett F.C.M.; Liggett S.B.; Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009,324(5923),55-59", "ArticleIdList": ["10.1126/science.1165557", "19213880"]}, {"Citation": "Andrup L.; Krogfelt K.A.; Hansen K.S.; Madsen A.M.; Transmission route of rhinovirus - the causative agent for common cold. A systematic review. Am J Infect Control 2023,51(8),938-957", "ArticleIdList": ["10.1016/j.ajic.2022.12.005", "36535318"]}, {"Citation": "Allan G.M.; Arroll B.; Prevention and treatment of the common cold: Making sense of the evidence. CMAJ 2014,186(3),190-199", "ArticleIdList": ["10.1503/cmaj.121442", "24468694"]}, {"Citation": "Fendrick A.M.; Monto A.S.; Nightengale B.; Sarnes M.; The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003,163(4),487-494", "ArticleIdList": ["10.1001/archinte.163.4.487", "12588210"]}, {"Citation": "Sauro A.; Barone F.; Blasio G.; Russo L.; Santillo L.; Do influenza and acute respiratory infective diseases weigh heavily on general practitioners\u2019 daily practice? Eur J Gen Pract 2006,12(1),34-36", "ArticleIdList": ["10.1080/13814780600757153", "16945870"]}, {"Citation": "Cohen S.; Tyrrell D.A.J.; Smith A.P.; Psychological stress and susceptibility to the common cold. N Engl J Med 1991,325(9),606-612", "ArticleIdList": ["10.1056/NEJM199108293250903", "1713648"]}, {"Citation": "Cohen S.; Doyle W.J.; Alper C.M.; Deverts J.D.; Turner R.B.; Sleep habits and susceptibility to the common cold. Arch Intern Med 2009,169(1),62-67", "ArticleIdList": ["10.1001/archinternmed.2008.505", "19139325"]}, {"Citation": "Ball T.M.; Holberg C.J.; Aldous M.B.; Martinez F.D.; Wright A.L.; Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med 2002,156(2),121-126", "ArticleIdList": ["10.1001/archpedi.156.2.121", "11814371"]}, {"Citation": "Pitk\u00e4ranta A.; Virolainen A.; Jero J.; Arruda E.; Hayden F.G.; Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998,102(2),291-295", "ArticleIdList": ["10.1542/peds.102.2.291", "9685428"]}, {"Citation": "Tam J.C.H.; Bidgood S.R.; McEwan W.A.; James L.C.; Intracellular sensing of complement C3 activates cell autonomous immunity. Science 2014,345(6201),1256070", "ArticleIdList": ["10.1126/science.1256070", "25190799"]}, {"Citation": "Matthews D.A.; Smith W.W.; Ferre R.A.; Condon B.; Budahazi G.; Slsson W.; Villafranca J.E.; Janson C.A.; McElroy H.E.; Gribskov C.L.; Worland S.; Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 1994,77(5),761-771", "ArticleIdList": ["10.1016/0092-8674(94)90059-0", "7515772"]}, {"Citation": "Yuan S.; Fan K.; Chen Z.; Sun Y.; Hou H.; Zhu L.; Structure of the HRV-C 3C-rupintrivir complex provides new insights for inhibitor design. Virol Sin 2020,35(4),445-454", "ArticleIdList": ["10.1007/s12250-020-00196-4", "32103448"]}, {"Citation": "Matthews D.A.; Dragovich P.S.; Webber S.E.; Fuhrman S.A.; Patick A.K.; Zalman L.S.; Hendrickson T.F.; Love R.A.; Prins T.J.; Marakovits J.T.; Zhou R.; Tikhe J.; Ford C.E.; Meador J.W.; Ferre R.A.; Brown E.L.; Binford S.L.; Brothers M.A.; DeLisle D.M.; Worland S.T.; Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci 1999,96(20),11000-11007", "ArticleIdList": ["10.1073/pnas.96.20.11000", "10500114"]}, {"Citation": "Binford S.L.; Maldonado F.; Brothers M.A.; Weady P.T.; Zalman L.S.; Meador J.W.; Matthews D.A.; Patick A.K.; Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother 2005,49(2),619-626", "ArticleIdList": ["10.1128/AAC.49.2.619-626.2005", "15673742"]}, {"Citation": "Fan X.; Li X.; Zhou Y.; Mei M.; Liu P.; Zhao J.; Peng W.; Jiang Z.B.; Yang S.; Iverson B.L.; Zhang G.; Yi L.; Quantitative analysis of the substrate specificity of human rhinovirus 3C protease and exploration of its substrate recognition mechanisms. ACS Chem Biol 2020,15(1),63-73", "ArticleIdList": ["10.1021/acschembio.9b00539", "31613083"]}, {"Citation": "Mello C.; Aguayo E.; Rodriguez M.; Lee G.; Jordan R.; Cihlar T.; Birkus G.; Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C. Antimicrob Agents Chemother 2014,58(3),1546-1555", "ArticleIdList": ["10.1128/AAC.01746-13", "24366736"]}, {"Citation": "Wang M.Q.; Chen S.H.; Human rhinovirus 3C protease as a potential target for the development of antiviral agents. Curr Protein Pept Sci 2007,8(1),19-27", "ArticleIdList": ["10.2174/138920307779941523", "17305557"]}, {"Citation": "Baxter A.; Chambers M.; Edfeldt F.; Edman K.; Freeman A.; Johansson C.; King S.; Morley A.; Petersen J.; Rawlins P.; Spadola L.; Thong B.; Po\u00ebl H.V.; Williams N.; Non-covalent inhibitors of rhinovirus 3C protease. Bioorg Med Chem Lett 2011,21(2),777-780", "ArticleIdList": ["10.1016/j.bmcl.2010.11.110", "21183345"]}, {"Citation": "Binford S.L.; Weady P.T.; Maldonado F.; Brothers M.A.; Matthews D.A.; Patick A.K.; in vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 2007,51(12),4366-4373", "ArticleIdList": ["10.1128/AAC.00905-07", "17908951"]}, {"Citation": "Theerawatanasirikul S.; Thangthamniyom N.; Kuo C.J.; Semkum P.; Phecharat N.; Chankeeree P.; Lekcharoensuk P.; Natural phytochemicals, luteolin and isoginkgetin, inhibit 3C protease and infection of FMDV, in silico and in vitro. Viruses 2021,13(11),2118", "ArticleIdList": ["10.3390/v13112118", "34834926"]}, {"Citation": "Patick A.K.; Brothers M.A.; Maldonado F.; Binford S.; Maldonado O.; Fuhrman S.; Petersen A.; Smith G.J.; Zalman L.S.; Burns-Naas L.A.; Tran J.Q.; in vitro antiviral activity and single- dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 2005,49(6),2267-2275", "ArticleIdList": ["10.1128/AAC.49.6.2267-2275.2005", "15917520"]}, {"Citation": "Hayden F.G.; Turner R.B.; Gwaltney J.M.; Burris C.K.; Gersten M.; Hsyu P.; Patick A.K.; Smith G.J.; Zalman L.S.; Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 2003,47(12),3907-3916", "ArticleIdList": ["10.1128/AAC.47.12.3907-3916.2003", "14638501"]}, {"Citation": "Smith A.; Matthews O.; Aromatic ointments for the common cold: What does the science say? Drugs Context 2022,11,2022-5-2022-6", "ArticleIdList": ["10.7573/dic.2022-5-6"]}, {"Citation": "Mammari N.; Albert Q.; Devocelle M.; Kenda M.; Glava\u010d K.N.; Dolenc S.M.; Mercolini L.; T\u00f3th J.; Milan N.; Czigle S.; Varbanov M.; Natural products for the prevention and treatment of common cold and viral respiratory infections. Pharmaceuticals 2023,16(5),662", "ArticleIdList": ["10.3390/ph16050662", "37242445"]}, {"Citation": "Ciprandi G.; Tosca M.A.; Non-pharmacological remedies for post-viral acute cough. Monaldi Arch Chest Dis 2021,92(1),1821", "ArticleIdList": ["34461702"]}, {"Citation": "Onyeogaziri F.C.; Papaneophytou C.; A general guide for the optimization of enzyme assay conditions using the design of experiments approach. SLAS Discov 2019,24(5),587-596", "ArticleIdList": ["10.1177/2472555219830084", "30802413"]}, {"Citation": "Antoniou G.; Papakyriacou I.; Papaneophytou C.; Optimization of soluble expression and purification of recombinant human rhinovirus type-14 3C protease using statistically designed experiments: Isolation and characterization of the enzyme. Mol Biotechnol 2017,59(9-10),407-424", "ArticleIdList": ["10.1007/s12033-017-0032-9", "28801725"]}, {"Citation": "Dallakyan S.; Olson A.J.; Chemical Biology: Methods and Protocols 2015,243-250", "ArticleIdList": ["10.1007/978-1-4939-2269-7_19"]}, {"Citation": "Theerawatanasirikul S.; Lekcharoensuk P.; in silico Modeling of Drugs against Coronaviruses: Computational Tools and Protocols 2021,661-681", "ArticleIdList": ["10.1007/7653_2020_63"]}, {"Citation": "Pettersen E.F.; Goddard T.D.; Huang C.C.; Couch G.S.; Greenblatt D.M.; Meng E.C.; Ferrin T.E.; UCSF Chimera\u2014A visualization system for exploratory research and analysis. J Comput Chem 2004,25(13),1605-1612", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Sayers E.W.; Barrett T.; Benson D.A.; Bolton E.; Bryant S.H.; Canese K.; Chetvernin V.; Church D.M.; DiCuccio M.; Federhen S.; Feolo M.; Fingerman I.M.; Geer L.Y.; Helmberg W.; Kapustin Y.; Landsman D.; Lipman D.J.; Lu Z.; Madden T.L.; Madej T.; Maglott D.R.; Bauer M.A.; Miller V.; Mizrachi I.; Ostell J.; Panchenko A.; Phan L.; Pruitt K.D.; Schuler G.D.; Sequeira E.; Sherry S.T.; Shumway M.; Sirotkin K.; Slotta D.; Souvorov A.; Starchenko G.; Tatusova T.A.; Wagner L.; Wang Y.; Wilbur W.J.; Yaschenko E.; Ye J.; Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2011,39(Database),D38-D51", "ArticleIdList": ["10.1093/nar/gkq1172", "21097890"]}, {"Citation": "Gallo K.; Kemmler E.; Goede A.; Becker F.; Dunkel M.; Preissner R.; Banerjee P.; SuperNatural 3.0\u2014A database of natural products and natural product-based derivatives. Nucleic Acids Res 2023,51(D1),D654-D659", "ArticleIdList": ["10.1093/nar/gkac1008", "36399452"]}, {"Citation": "Copeland R.A.; Enzymes: A practical introduction to structure, mechanism, and data analysis 2000,266-304", "ArticleIdList": ["10.1002/0471220639.ch8"]}, {"Citation": "Vlasiou M.; Nicolaidou V.; Papaneophytou C.; Targeting lactate dehydrogenase-B as a strategy to fight cancer: Identification of potential inhibitors by in silico analysis and in vitro screening. Pharmaceutics 2023,15(10),2411", "ArticleIdList": ["10.3390/pharmaceutics15102411", "37896171"]}, {"Citation": "Dragovich P.S.; Prins T.J.; Zhou R.; Johnson T.O.; Hua Y.; Luu H.T.; Sakata S.K.; Brown E.L.; Maldonado F.C.; Tuntland T.; Lee C.A.; Fuhrman S.A.; Zalman L.S.; Patick A.K.; Matthews D.A.; Wu E.Y.; Guo M.; Borer B.C.; Nayyar N.K.; Moran T.; Chen L.; Rejto P.A.; Rose P.W.; Guzman M.C.; Dovalsantos E.Z.; Lee S.; McGee K.; Mohajeri M.; Liese A.; Tao J.; Kosa M.B.; Liu B.; Batugo M.R.; Gleeson J.P.R.; Wu Z.P.; Liu J.; Meador J.W.; Ferre R.A.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. J Med Chem 2003,46(21),4572-4585", "ArticleIdList": ["10.1021/jm030166l", "14521419"]}, {"Citation": "Mohutsky M.; Hall S.D.; Enzyme Kinetics in drug Metabolism: Fundamentals and Applications 2014,57-91", "ArticleIdList": ["10.1007/978-1-62703-758-7_5"]}, {"Citation": "Chojnacka K.; Krowiak W.A.; Skrzypczak D.; Mikula K.; M\u0142ynarz P.; Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus. J Funct Foods 2020,73,104146", "ArticleIdList": ["10.1016/j.jff.2020.104146", "32834835"]}, {"Citation": "Heikkinen T.; J\u00e4rvinen A.; The common cold. Lancet 2003,361(9351),51-59", "ArticleIdList": ["10.1016/S0140-6736(03)12162-9", "12517470"]}, {"Citation": "Zephyr J.; Yilmaz K.N.; Schiffer C.A.; Viral proteases: Structure, mechanism and inhibition. Enzymes 2021,50,301-333", "ArticleIdList": ["10.1016/bs.enz.2021.09.004", "34861941"]}, {"Citation": "Duechler M.; Skern T.; Sommergruber W.; Neubauer C.; Gruendler P.; Fogy I.; Blaas D.; Kuechler E.; Evolutionary relationships within the human rhinovirus genus: Comparison of serotypes 89, 2, and 14. Proc Natl Acad Sci 1987,84(9),2605-2609", "ArticleIdList": ["10.1073/pnas.84.9.2605", "3033653"]}, {"Citation": "Hughes P.J.; North C.; Jellis C.H.; Minor P.D.; Stanway G.; The nucleotide sequence of human rhinovirus 1B: Molecular relationships within the rhinovirus genus. J Gen Virol 1988,69(1),49-58", "ArticleIdList": ["10.1099/0022-1317-69-1-49", "2826669"]}, {"Citation": "Lee W.M.; Wang W.; Rueckert R.R.; Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes 1995,9(2),177-181", "ArticleIdList": ["10.1007/BF01702661", "7732663"]}, {"Citation": "Skern T.; Sommergruber W.; Blaas D.; Gruendler P.; Fraundorfer F.; Pieler C.; Fogy I.; Kuechler E.; Human rhinovirus 2: Complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Res 1985,13(6),2111-2126", "ArticleIdList": ["10.1093/nar/13.6.2111", "2987843"]}, {"Citation": "Stanway G.; Hughes P.J.; Mountford R.C.; Minor P.D.; Almond J.W.; The complete nucleotide sequence of a common cold virus: Human rhinovlrus 14. Nucleic Acids Res 1984,12(20),7859-7875", "ArticleIdList": ["10.1093/nar/12.20.7859", "6093056"]}, {"Citation": "Werner G.; Rosenwirth B.; Bauer E.; Seifert J.M.; Werner F.J.; Besemer J.; Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol 1986,57(3),1084-1093", "ArticleIdList": ["10.1128/jvi.57.3.1084-1093.1986", "3512851"]}, {"Citation": "Buthelezi N.M.; Machaba K.E.; Soliman M.E.; The Identification of potential human rhinovirus inhibitors: Exploring the binding landscape of HRV-3C protease through PRED pharmacophore screening. Future Virol 2017,12(12),747-759", "ArticleIdList": ["10.2217/fvl-2017-0084"]}, {"Citation": "Reich S.H.; Johnson T.; Wallace M.B.; Kephart S.E.; Fuhrman S.A.; Worland S.T.; Matthews D.A.; Hendrickson T.F.; Chan F.; Meador J.; Ferre R.A.; Brown E.L.; DeLisle D.M.; Patick A.K.; Binford S.L.; Ford C.E.; Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation. J Med Chem 2000,43(9),1670-1683", "ArticleIdList": ["10.1021/jm9903242", "10794684"]}, {"Citation": "Sawant R.T.; Waghmode S.B.; Organocatalytic enantioselective formal synthesis of HRV 3C-protease inhibitor (1R,3S)-thysanone. Tetrahedron 2009,65(8),1599-1602", "ArticleIdList": ["10.1016/j.tet.2008.12.060"]}, {"Citation": "Singh S.B.; Cordingley M.G.; Ball R.G.; Smith J.L.; Dombrowski A.W.; Goetz M.A.; Structure of stereochemistry of thysanone: A novel human rhinovirus 3C-protease inhibitor from Thysanophora penicilloides. Tetrahedron Lett 1991,32(39),5279-5282", "ArticleIdList": ["10.1016/S0040-4039(00)92364-5"]}, {"Citation": "Jeong Y.J.; Sperry J.; Taylor J.A.; Brimble M.A.; Synthesis and evaluation of 9-deoxy analogues of (\u2212)-thysanone, an inhibitor of HRV 3C protease. Eur J Med Chem 2014,87,220-227", "ArticleIdList": ["10.1016/j.ejmech.2014.09.063", "25259514"]}, {"Citation": "Dragovich P.S.; Prins T.J.; Zhou R.; Webber S.E.; Marakovits J.T.; Fuhrman S.A.; Patick A.K.; Matthews D.A.; Lee C.A.; Ford C.E.; Burke B.J.; Rejto P.A.; Hendrickson T.F.; Tuntland T.; Brown E.L.; Meador J.W.; Ferre R.A.; Harr J.E.V.; Kosa M.B.; Worland S.T.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. J Med Chem 1999,42(7),1213-1224", "ArticleIdList": ["10.1021/jm9805384", "10197965"]}, {"Citation": "Jain S.; Amin S.A.; Adhikari N.; Jha T.; Gayen S.; Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: Identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. J Biomol Struct Dyn 2020,38(1),66-77", "ArticleIdList": ["10.1080/07391102.2019.1566093", "30646829"]}, {"Citation": "Nakano Y.; Watari T.; Adachi K.; Watanabe K.; Otsuki K.; Amano Y.; Takaki Y.; Onigata K.; Survey of potentially inappropriate prescriptions for common cold symptoms in Japan: A cross- sectional study. PLoS One 2022,17(5),e0265874", "ArticleIdList": ["10.1371/journal.pone.0265874", "35552542"]}, {"Citation": "Catarino M.D.; Talhi O.; Rabahi A.; Silva A.M.S.; Cardoso S.M.; The antiinflammatory potential of flavonoids: Mechanistic aspects. Stud Nat Prod Chem 2016,48,65-99"}, {"Citation": "Lo A.H.; Liang Y.C.; Lin-Shiau S.Y.; Ho C.T.; Lin J.K.; Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-\u03baB in mouse macrophages. Carcinogenesis 2002,23(6),983-991", "ArticleIdList": ["10.1093/carcin/23.6.983", "12082020"]}, {"Citation": "Johnson J.J.; Carnosol: A promising anti-cancer and anti-inflammatory agent. Cancer Lett 2011,305(1),1-7", "ArticleIdList": ["10.1016/j.canlet.2011.02.005", "21382660"]}, {"Citation": "Guan H.; Luo W.; Bao B.; Cao Y.; Cheng F.; Yu S.; Fan Q.; Zhang L.; Wu Q.; Shan M.; A comprehensive review of rosmarinic acid: From phytochemistry to pharmacology and its new insight. Molecules 2022,27(10),3292", "ArticleIdList": ["10.3390/molecules27103292", "35630768"]}, {"Citation": "Panayi T.; Sarigiannis Y.; Mourelatou E.; Hapeshis E.; Papaneophytou C.; Anti-quorum-sensing potential of ethanolic extracts of aromatic plants from the flora of cyprus. Plants 2022,11(19),2632", "ArticleIdList": ["10.3390/plants11192632", "36235498"]}, {"Citation": "Nadeem M.; Imran M.; Gondal A.T.; Imran A.; Shahbaz M.; Amir M.R.; Sajid W.M.; Qaisrani B.T.; Atif M.; Hussain G.; Salehi B.; Ostrander A.E.; Martorell M.; Rad S.J.; Cho C.W.; Martins N.; Therapeutic potential of rosmarinic acid: A comprehensive review. Appl Sci 2019,9(15),3139", "ArticleIdList": ["10.3390/app9153139"]}, {"Citation": "Jheng J.R.; Hsieh C.F.; Chang Y.H.; Ho J.Y.; Tang W.F.; Chen Z.Y.; Liu C.J.; Lin T.J.; Huang L.Y.; Chern J.H.; Horng J.T.; Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3\u03b2 and phosphorylated AKT expression levels. J Microbiol Immunol Infect 2022,55(4),598-610", "ArticleIdList": ["10.1016/j.jmii.2022.04.012", "35650006"]}, {"Citation": "Lin W.Y.; Yu Y.J.; Jinn T.R.; Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study. Virol J 2019,16(1),94", "ArticleIdList": ["10.1186/s12985-019-1203-z", "31366366"]}, {"Citation": "Patel U.; Desai K.; Dabhi R.C.; Maru J.J.; Shrivastav P.S.; Bioprospecting phytochemicals of Rosmarinus officinalis L. for targeting SARS-CoV-2 main protease (M): A computational study. J Mol Model 2023,29(5),161", "ArticleIdList": ["10.1007/s00894-023-05569-6", "37115321"]}, {"Citation": "Tumskiy R.S.; Tumskaia A.V.; Klochkova I.N.; Richardson R.J.; SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations. Comput Biol Med 2023,153,106449", "ArticleIdList": ["10.1016/j.compbiomed.2022.106449", "36586228"]}, {"Citation": "Hossain A.; Rahman M.E.; Rahman M.S.; Nasirujjaman K.; Matin M.N.; Faruqe M.O.; Rabbee M.F.; Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS- CoV-2 main protease (M) using molecular docking and deep learning methods. Comput Biol Med 2023,157,106785", "ArticleIdList": ["10.1016/j.compbiomed.2023.106785", "36931201"]}, {"Citation": "Mahmood R.A.; Hasan A.; Rahmatullah M.; Paul A.K.; Jahan R.; Jannat K.; Bondhon T.A.; Mahboob T.; Nissapatorn V.; Pereira L.M.; Paul T.K.; Rumi O.H.; Wiart C.; Wilairatana P.; Solanaceae family phytochemicals as inhibitors of 3C-like protease of SARS-CoV-2: An in silico analysis. Molecules 2022,27(15),4739", "ArticleIdList": ["10.3390/molecules27154739", "35897915"]}, {"Citation": "Sweeney T.R.; Rosell R.N.; Birtley J.R.; Leatherbarrow R.J.; Curry S.; Structural and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals the role of the beta-ribbon in proteolysis. J Virol 2007,81(1),115-124", "ArticleIdList": ["10.1128/JVI.01587-06", "17065215"]}, {"Citation": "Leong L.E.; Walker P.A.; Porter A.G.; Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5\u2032-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities. J Biol Chem 1993,268(34),25735-25739", "ArticleIdList": ["10.1016/S0021-9258(19)74451-2", "8245010"]}, {"Citation": "Lin Y.J.; Chang Y.C.; Hsiao N.W.; Hsieh J.L.; Wang C.Y.; Kung S.H.; Tsai F.J.; Lan Y.C.; Lin C.W.; Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods 2012,182(1-2),93-98", "ArticleIdList": ["10.1016/j.jviromet.2012.03.020", "22465253"]}, {"Citation": "Smith E.; Gardner D.M.E.; Ordonez G.R.D.; Nguyen T.T.; Hull M.; Chen E.; Yu X.; Bannister T.D.; Baillargeon P.; Scampavia L.; Griffin P.; Farzan M.; Spicer T.P.; High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2. SLAS Discov 2023,28(3),95-101", "ArticleIdList": ["10.1016/j.slasd.2023.01.001", "36646172"]}, {"Citation": "Brown A.S.; Ackerley D.F.; Calcott M.J.; High-throughput screening for inhibitors of the SARS-CoV-2 protease using a FRET-biosensor. Molecules 2020,25(20),4666", "ArticleIdList": ["10.3390/molecules25204666", "33066278"]}, {"Citation": "Rothan H.A.; Teoh T.C.; Cell-based high-throughput screening protocol for discovering antiviral inhibitors against SARS-CoV-2 main protease (3CLpro). Mol Biotechnol 2021,63(3),240-248", "ArticleIdList": ["10.1007/s12033-021-00299-7", "33464543"]}]}], "History": [{"Year": "2024", "Month": "3", "Day": "4"}, {"Year": "2024", "Month": "4", "Day": "14"}, {"Year": "2024", "Month": "4", "Day": "17"}, {"Year": "2024", "Month": "7", "Day": "24", "Hour": "6", "Minute": "41"}, {"Year": "2024", "Month": "5", "Day": "3", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "3", "Hour": "3", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38698747", "10.2174/0115680266308561240427065854", "CTMC-EPUB-140135"]}}]}